POIETIS leverages its experience and expertise in skin bioprinting to develop a first therapeutic product to treat chronic wound healing tissus such as diabetic foot ulcers or venous ulcers.

In collaboration with leading clinicians, POIETIS develops a 3D bioprinted patch for myocardial repair and a 3D bioprinted heart valve.

Poietis and Prometheus, division of skeletal tissue engineering of KU Leuven, entered into a Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.

Want to be part of our Clinical challenges ?

You can contact us at and we will get in touch with you.